D. L. Carrell

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC)

John D. Hainsworth, Jeffrey A. Sosman, David R. Spigel et al. · Journal of Clinical Oncology · 2004 · 54 citations

Medicine, Oncology, Pharmacology +17

Phase II trial of rituximab and short duration chemotherapy followed by ⁹⁰Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Dianna Shipley, David R. Spigel, D. L. Carrell et al. · Journal of Clinical Oncology · 2004 · 25 citations

Medicine, Oncology, Pharmacotherapy +13

Weekly combination chemotherapy with docetaxel and gemcitabine as first‐line treatment for elderly patients and patients with poor performance status who have extensive‐stage small cell lung carcinoma

John D. Hainsworth, D. L. Carrell, Ronald Drengler et al. · Cancer · 2004 · 24 citations

Medicine, Oncology, Pharmacotherapy +13

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC)

John D. Hainsworth, Jeffrey A. Sosman, David R. Spigel et al. · Journal of Clinical Oncology · 2004 · 14 citations

Medicine, Oncology, Pharmacology +17

Phase II trial of rituximab and short duration chemotherapy followed by ⁹⁰Y-ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: A Minnie Pearl Cancer Research Network phase II trial

Dianna Shipley, David R. Spigel, D. L. Carrell et al. · Journal of Clinical Oncology · 2004 · 11 citations

Medicine, Oncology, Pharmacotherapy +13